Altimmune (ALT) Receivables - Net (2009 - 2026)
Altimmune (ALT) recorded Receivables - Net of $3.34 million in Q2 2026, up 940.8% from $321,000 a year earlier and up 100.7% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Altimmune reported Receivables - Net of $1.22 million, up 124.1% from FY2024.
- Annual Receivables - Net has a three-year compound annual growth rate of 91.7% (FY2022 to FY2025).
- Across earlier years, Receivables - Net came in at $544,000 in FY2024 (-51.0%), $1.11 million in FY2023 (+542.2%) and $173,000 in FY2022.
- The Q2 2026 figure is the highest quarterly Receivables - Net since Q4 2013.
- On a year-over-year basis, Receivables - Net has increased for four consecutive quarters, with growth averaging 197.2% over the last seven quarters.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 940.8% in Q2 2026, against a decline of 51.0% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.67 million (Q1 2026), $1.22 million (Q4 2025) and $845,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Altimmune | 377.28 Mn | -764.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.34 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 845,000.00 |
| Jun 30, 2025 | 321,000.00 |
| Mar 31, 2025 | 507,000.00 |
| Dec 31, 2024 | 544,000.00 |
| Sep 30, 2024 | 428,000.00 |
| Jun 30, 2024 | 424,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 876,000.00 |
| Jun 30, 2023 | 136,000.00 |
| Mar 31, 2023 | 252,000.00 |
| Dec 31, 2022 | 173,000.00 |
| Sep 30, 2022 | 633,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 429,000.00 |
| Sep 30, 2021 | 1.57 Mn |
API Access
Altimmune Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();